Equity Capital Markets

Company · CIK 1367461

King Pharmaceuticals Research & Development, Inc.

CIK1367461 (SEC EDGAR)
Incorporated inDE
Business addressNC
Listedno ticker on SEC record today
First annual or quarterly reportnone on EDGAR

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-135285-04
ShelfEffective
2006-06-262006-06-261

Filings

1
FiledFilingRegistrationAccession
2006-06-26S-3ASRShelf registered 333-135285-040000950144-06-006180

All filings of this company · CSV